After working together on connected diabetes solutions for the past six years, Abbott and Bigfoot Biomedical have decided to take the relationship to the next level.
Abbott has agreed to acquire Bigfoot. The deal is expected to close in the third quarter, but financial terms were not disclosed.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,